Kanta Subbarao

43.6k total citations · 12 hit papers
305 papers, 27.4k citations indexed

About

Kanta Subbarao is a scholar working on Epidemiology, Infectious Diseases and Agronomy and Crop Science. According to data from OpenAlex, Kanta Subbarao has authored 305 papers receiving a total of 27.4k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Epidemiology, 159 papers in Infectious Diseases and 65 papers in Agronomy and Crop Science. Recurrent topics in Kanta Subbarao's work include Influenza Virus Research Studies (209 papers), Respiratory viral infections research (148 papers) and SARS-CoV-2 and COVID-19 Research (88 papers). Kanta Subbarao is often cited by papers focused on Influenza Virus Research Studies (209 papers), Respiratory viral infections research (148 papers) and SARS-CoV-2 and COVID-19 Research (88 papers). Kanta Subbarao collaborates with scholars based in United States, Australia and United Kingdom. Kanta Subbarao's co-authors include Brian R. Murphy, Nancy J. Cox, Anjeanette Roberts, Leatrice Vogel, Elaine W. Lamirande, Catharine I. Paules, Xiyan Xu, William T. London, Catherine J. Luke and Stephen J. Kent and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Kanta Subbarao

301 papers receiving 26.7k citations

Hit Papers

Neutralizing antibody lev... 1993 2026 2004 2015 2021 1998 1993 1999 2000 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
    2021 2.1k citations David S. Khoury, Deborah Cromer et al. profile →
  2. Characterization of an Avian Influenza A (H5N1) Virus Isolated from a Child with a Fatal Respiratory Illness
    1998 1.1k citations Kanta Subbarao, Thomas Rowe et al. profile →
  3. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range
    1993 749 citations Kanta Subbarao et al. Journal of Virology profile →
  4. Genetic Characterization of the Pathogenic Influenza A/Goose/Guangdong/1/96 (H5N1) Virus: Similarity of Its Hemagglutinin Gene to Those of H5N1 Viruses from the 1997 Outbreaks in Hong Kong
    1999 625 citations Xiyan Xu, Kanta Subbarao et al. profile →
  5. Global Epidemiology of Influenza: Past and Present
    2000 625 citations Kanta Subbarao et al. profile →
  6. Systems biology of vaccination for seasonal influenza in humans
    2011 587 citations Kanta Subbarao et al. profile →
  7. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
    2004 541 citations Kanta Subbarao et al. profile →
  8. Influenza
    2017 541 citations Kanta Subbarao et al. profile →
  9. Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolates
    2000 520 citations Kanta Subbarao et al. Proceedings of the National Academy of Sciences profile →
  10. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
    2004 509 citations Anjeanette Roberts, Kanta Subbarao et al. profile →
  11. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
    2004 503 citations Kanta Subbarao et al. profile →
  12. Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
    2023 72 citations David S. Khoury, Deborah Cromer et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kanta Subbarao 15.3k 14.8k 5.9k 4.8k 4.1k 305 27.4k
Vincent J. Munster 10.2k 0.7× 14.9k 1.0× 2.2k 0.4× 5.2k 1.1× 2.5k 0.6× 219 23.0k
Richard J. Webby 18.1k 1.2× 9.3k 0.6× 6.0k 1.0× 8.6k 1.8× 4.4k 1.0× 507 25.3k
Guus F. Rimmelzwaan 19.6k 1.3× 9.0k 0.6× 7.8k 1.3× 6.5k 1.4× 4.2k 1.0× 339 25.9k
Theo M. Bestebroer 9.6k 0.6× 10.3k 0.7× 2.1k 0.4× 3.7k 0.8× 2.5k 0.6× 113 17.6k
Ron A. M. Fouchier 30.2k 2.0× 25.7k 1.7× 8.0k 1.3× 10.9k 2.3× 6.5k 1.6× 462 48.0k
Florian Krammer 11.9k 0.8× 11.0k 0.7× 6.9k 1.2× 1.4k 0.3× 4.5k 1.1× 368 22.9k
Lin‐Fa Wang 9.3k 0.6× 18.6k 1.3× 2.6k 0.4× 1.7k 0.4× 3.8k 0.9× 456 26.4k
Terrence M. Tumpey 17.9k 1.2× 6.7k 0.5× 8.3k 1.4× 5.4k 1.1× 4.0k 1.0× 275 23.2k
Maria Zambon 12.1k 0.8× 8.9k 0.6× 3.1k 0.5× 1.8k 0.4× 2.5k 0.6× 277 19.5k
Jacqueline M. Katz 19.0k 1.2× 7.9k 0.5× 7.4k 1.2× 6.5k 1.4× 3.2k 0.8× 275 23.6k

Countries citing papers authored by Kanta Subbarao

Since Specialization
Citations

This map shows the geographic impact of Kanta Subbarao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanta Subbarao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanta Subbarao more than expected).

Fields of papers citing papers by Kanta Subbarao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanta Subbarao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanta Subbarao. The network helps show where Kanta Subbarao may publish in the future.

Co-authorship network of co-authors of Kanta Subbarao

This figure shows the co-authorship network connecting the top 25 collaborators of Kanta Subbarao. A scholar is included among the top collaborators of Kanta Subbarao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanta Subbarao. Kanta Subbarao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gartner, Matthew J., Monique L. Smith, Clyde Dapat, et al.. (2025). Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strains. Journal of Virology. 99(9). e0068425–e0068425. 1 indexed citations
2.
Barr, Ian & Kanta Subbarao. (2024). Implications of the apparent extinction of B/Yamagata-lineage human influenza viruses. npj Vaccines. 9(1). 219–219. 5 indexed citations
3.
Waldock, Joanna, Rebecca Jane Cox, Kanta Subbarao, et al.. (2024). Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK. Influenza and Other Respiratory Viruses. 18(11). e70014–e70014.
4.
Chen, Joseph, Jessica A. Neil, Jianping Tan, et al.. (2023). A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts. Nature Cell Biology. 25(8). 1223–1234. 20 indexed citations
5.
Mordant, Francesca L., Olivia Price, Rajeev Rudraraju, et al.. (2022). Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months. Influenza and Other Respiratory Viruses. 17(1). e13072–e13072. 11 indexed citations
6.
Lee, Leo, Vera Ignjatović, Damian F. J. Purcell, et al.. (2022). Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial Cells. Viruses. 14(12). 2620–2620. 8 indexed citations
7.
Sutton, Troy C., Elaine W. Lamirande, Rita Czakó, et al.. (2022). Sequential Transmission of Influenza Viruses in Ferrets Does Not Enhance Infectivity and Does Not Predict Transmissibility in Humans. mBio. 13(6). e0254022–e0254022. 9 indexed citations
8.
Nicholson, Suellen, Theo Karapanagiotidis, Arseniy Khvorov, et al.. (2021). Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance. Open Forum Infectious Diseases. 8(7). ofab239–ofab239. 15 indexed citations
9.
Chang, Jessie J.‐Y., Miranda E. Pitt, George Taiaroa, et al.. (2021). Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection. Cell Reports. 35(6). 109108–109108. 24 indexed citations
10.
Bond, Katherine, Suellen Nicholson, Seok Lim, et al.. (2020). Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting. The Journal of Infectious Diseases. 222(8). 1280–1288. 38 indexed citations
11.
Huddleston, John, John Barnes, Thomas Rowe, et al.. (2020). Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution. eLife. 9. 40 indexed citations
12.
Lambert, Paul‐Henri, Donna M. Ambrosino, Svein Rune Andersen, et al.. (2020). Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine. 38(31). 4783–4791. 73 indexed citations
13.
Khoury, David S., Adam K. Wheatley, Mitchell D. Ramuta, et al.. (2020). Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nature reviews. Immunology. 20(12). 727–738. 81 indexed citations
14.
Koutsakos, Marios, Katherine Kedzierska, & Kanta Subbarao. (2019). Immune Responses to Avian Influenza Viruses. The Journal of Immunology. 202(2). 382–391. 51 indexed citations
15.
Korenkov, Daniil, Karen Laurie, Patrick C. Reading, et al.. (2018). Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model. Infection Genetics and Evolution. 64. 95–104. 12 indexed citations
16.
Whitehead, Stephen S., Anna P. Durbin, Kristen K. Pierce, et al.. (2017). In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination. PLoS neglected tropical diseases. 11(5). e0005584–e0005584. 80 indexed citations
17.
He, Xiaosong, Sanae Sasaki, Surender Khurana, et al.. (2012). Heterovariant Cross-Reactive B-Cell Responses Induced by the 2009 Pandemic Influenza Virus A Subtype H1N1 Vaccine. The Journal of Infectious Diseases. 207(2). 288–296. 17 indexed citations
18.
Chen, Grace, et al.. (2011). Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine. Proceedings of the National Academy of Sciences. 108(3). 1140–1145. 49 indexed citations
19.
Roberts, Anjeanette, Damon Deming, Christopher D. Paddock, et al.. (2007). A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice. PLoS Pathogens. 3(1). e5–e5. 335 indexed citations
20.
Subbarao, Kanta. (1999). Influenza Vaccines: Present and Future. Advances in virus research. 54. 349–373. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent J. Munster Breakdown of academic impact, for papers by Richard J. Webby Breakdown of academic impact, for papers by Guus F. Rimmelzwaan Breakdown of academic impact, for papers by Theo M. Bestebroer Breakdown of academic impact, for papers by Ron A. M. Fouchier Breakdown of academic impact, for papers by Florian Krammer Breakdown of academic impact, for papers by Lin‐Fa Wang Breakdown of academic impact, for papers by Terrence M. Tumpey Breakdown of academic impact, for papers by Maria Zambon Breakdown of academic impact, for papers by Jacqueline M. Katz
Rankless by CCL
2026